Chemed Management

Management criteria checks 3/4

Chemed's CEO is Kevin McNamara, appointed in Aug 1994, has a tenure of 30.33 years. total yearly compensation is $12.63M, comprised of 12.7% salary and 87.3% bonuses, including company stock and options. directly owns 0.68% of the company’s shares, worth €50.87M. The average tenure of the management team and the board of directors is 24.6 years and 15.6 years respectively.

Key information

Kevin McNamara

Chief executive officer

US$12.6m

Total compensation

CEO salary percentage12.7%
CEO tenure30.3yrs
CEO ownership0.7%
Management average tenure24.6yrs
Board average tenure15.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Kevin McNamara's remuneration changed compared to Chemed's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$302m

Jun 30 2024n/an/a

US$301m

Mar 31 2024n/an/a

US$283m

Dec 31 2023US$13mUS$2m

US$273m

Sep 30 2023n/an/a

US$245m

Jun 30 2023n/an/a

US$226m

Mar 31 2023n/an/a

US$240m

Dec 31 2022US$12mUS$1m

US$250m

Sep 30 2022n/an/a

US$262m

Jun 30 2022n/an/a

US$277m

Mar 31 2022n/an/a

US$267m

Dec 31 2021US$12mUS$1m

US$269m

Sep 30 2021n/an/a

US$308m

Jun 30 2021n/an/a

US$303m

Mar 31 2021n/an/a

US$329m

Dec 31 2020US$12mUS$1m

US$319m

Sep 30 2020n/an/a

US$271m

Jun 30 2020n/an/a

US$263m

Mar 31 2020n/an/a

US$231m

Dec 31 2019US$10mUS$1m

US$220m

Sep 30 2019n/an/a

US$209m

Jun 30 2019n/an/a

US$201m

Mar 31 2019n/an/a

US$205m

Dec 31 2018US$9mUS$1m

US$206m

Sep 30 2018n/an/a

US$206m

Jun 30 2018n/an/a

US$190m

Mar 31 2018n/an/a

US$113m

Dec 31 2017US$8mUS$1m

US$98m

Compensation vs Market: Kevin's total compensation ($USD12.63M) is above average for companies of similar size in the German market ($USD3.33M).

Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.


CEO

Kevin McNamara (70 yo)

30.3yrs

Tenure

US$12,625,106

Compensation

Mr. Kevin J. McNamara has been the Chief Executive Officer of Chemed Corporation since May 2001 and has been its President since August 2, 1994. Previously, Mr. McNamara served as an Executive Vice Preside...


Leadership Team

NamePositionTenureCompensationOwnership
Kevin McNamara
CEO, President & Director30.3yrsUS$12.63m0.68%
€ 50.9m
Michael Witzeman
VP, Controller12.6yrsUS$2.93m0.025%
€ 1.9m
Spencer Lee
Executive Vice President24.6yrsUS$3.37m0.12%
€ 9.1m
Thomas Hutton
VP & Director36.8yrsno data0.56%
€ 41.9m
Nicholas Westfall
Executive Vice President8.5yrsUS$4.71m0.041%
€ 3.1m
Lisa Reinhard
VP, Chief Administrative Officer & Secretary30.1yrsno datano data
Sherri Warner
Director of Investor Relationsno datano datano data
Brian Judkins
VP, Secretary & Chief Legal Officer4.3yrsno data0.010%
€ 766.6k
Nathan McNamara
VP & Chief Strategy Officerno datano datano data

24.6yrs

Average Tenure

52.5yo

Average Age

Experienced Management: CXM's management team is seasoned and experienced (24.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kevin McNamara
CEO, President & Director37.9yrsUS$12.63m0.68%
€ 50.9m
Thomas Hutton
VP & Director39.9yrsno data0.56%
€ 41.9m
Thomas Rice
Independent Director15.6yrsUS$278.27k0.040%
€ 3.0m
Sandra Laney
Director Emeritus15.6yrsUS$157.02kno data
Patrick Grace
Independent Director28.9yrsUS$308.60k0.022%
€ 1.6m
George Walsh
Independent Chairman29.9yrsUS$453.15k0.023%
€ 1.7m
Andrea Lindell
Independent Director16.6yrsUS$272.77k0.038%
€ 2.9m
Christopher Heaney
Independent Director4.6yrsUS$279.43k0.014%
€ 1.1m
Ron DeLyons
Independent Director4.6yrsUS$278.27k0.0093%
€ 694.2k
John Mount
Independent Director2.3yrsUS$278.27k0.0044%
€ 326.2k
Eileen McCarthy
Independent Director1.6yrsUS$238.52k0.0039%
€ 288.9k

15.6yrs

Average Tenure

70yo

Average Age

Experienced Board: CXM's board of directors are seasoned and experienced ( 15.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 08:34
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Chemed Corporation is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Adam FeinsteinBarclays
Joanna Sylvia GajukBofA Global Research